Opinion: AARP was wrong to back Medicare drug price control. It'll end up hurting seniors

By AZ Central
| November 14, 2022

The celebrated Inflation Reduction Act doesn't reduce inflation. Worse, it'll stymie drug research and development that hurt seniors' access to drugs.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...